CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise | +21,327 | 81,327 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Shares withheld for taxes | −10,313 | $48.13 | $496K | 71,014 |
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Share Option | +120,150 | 120,150 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Restricted Share Unit | +30,050 | 30,050 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Grant or award · Performance Share Unit | +60,100 | 60,100 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,481 | 6,481 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −6,237 | 12,475 | ||
| 2026-04-01 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Restricted Share Unit | −8,609 | 25,826 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise | +7,564 | 34,982 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −3,205 | $48.13 | $154K | 31,777 |
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Share Option | +14,600 | 14,600 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Share Unit | +3,650 | 3,650 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award · Performance Share Unit | +7,300 | 7,300 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,558 | 2,557 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,362 | 4,725 | ||
| 2026-04-01 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit | −2,644 | 7,931 | ||
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +2,036 | $22.89 | $47K | 14,122 |
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,513 | $17.76 | $187K | 24,635 |
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +13,813 | $18.06 | $249K | 38,448 |
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +10,360 | $26.74 | $277K | 48,808 |
Page 16 of 74 · 1,467 trades